JP2008050375A5 - - Google Patents

Download PDF

Info

Publication number
JP2008050375A5
JP2008050375A5 JP2007294088A JP2007294088A JP2008050375A5 JP 2008050375 A5 JP2008050375 A5 JP 2008050375A5 JP 2007294088 A JP2007294088 A JP 2007294088A JP 2007294088 A JP2007294088 A JP 2007294088A JP 2008050375 A5 JP2008050375 A5 JP 2008050375A5
Authority
JP
Japan
Prior art keywords
drug carrier
vitamin
activity
analog
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007294088A
Other languages
English (en)
Japanese (ja)
Other versions
JP4533420B2 (ja
JP2008050375A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2007294088A priority Critical patent/JP4533420B2/ja
Priority claimed from JP2007294088A external-priority patent/JP4533420B2/ja
Publication of JP2008050375A publication Critical patent/JP2008050375A/ja
Publication of JP2008050375A5 publication Critical patent/JP2008050375A5/ja
Application granted granted Critical
Publication of JP4533420B2 publication Critical patent/JP4533420B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007294088A 2004-12-22 2007-11-13 線維化抑制のための薬物担体および薬物担体キット Expired - Fee Related JP4533420B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007294088A JP4533420B2 (ja) 2004-12-22 2007-11-13 線維化抑制のための薬物担体および薬物担体キット

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004382791 2004-12-22
JP2007294088A JP4533420B2 (ja) 2004-12-22 2007-11-13 線維化抑制のための薬物担体および薬物担体キット

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006549061A Division JP4121537B2 (ja) 2004-12-22 2005-12-22 線維化抑制のための薬物担体および薬物担体キット

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010049297A Division JP5172880B2 (ja) 2004-12-22 2010-03-05 線維化抑制のための薬物担体および薬物担体キット

Publications (3)

Publication Number Publication Date
JP2008050375A JP2008050375A (ja) 2008-03-06
JP2008050375A5 true JP2008050375A5 (https=) 2009-12-17
JP4533420B2 JP4533420B2 (ja) 2010-09-01

Family

ID=39234728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007294088A Expired - Fee Related JP4533420B2 (ja) 2004-12-22 2007-11-13 線維化抑制のための薬物担体および薬物担体キット

Country Status (1)

Country Link
JP (1) JP4533420B2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE056941T2 (hu) 2004-12-22 2022-04-28 Nitto Denko Corp Gyógyszerhordozó és gyógyszerhordozó kit fibrózis gátlására
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
TWI407971B (zh) 2007-03-30 2013-09-11 日東電工股份有限公司 Cancer cells and tumor-related fibroblasts
EP2368989A4 (en) 2008-11-26 2012-09-26 Chugai Pharmaceutical Co Ltd OLIGORIBONUCLEOTID- BZW. PEPTID NUCLEIC ACID TO INHIBIT THE ACTIVITY OF HEPATITIS C VIRUS
CN102292069B (zh) 2008-11-26 2014-07-30 中外制药株式会社 囊泡制剂
CN105473147A (zh) * 2013-04-24 2016-04-06 萨克生物研究学院 维生素d受体/smad基因组回路门纤维化反应
WO2019023149A1 (en) 2017-07-24 2019-01-31 Salk Institute For Biological Studies USE OF BROMODOMAIN-CONTAINING PROTEIN-9 ANTAGONISTS IN ASSOCIATION WITH VITAMIN D RECEPTOR AGONISTS IN THE TREATMENT OF DIABETES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US20020012998A1 (en) * 2000-03-29 2002-01-31 Igor Gonda Cationic liposomes
JP2002047211A (ja) * 2000-08-04 2002-02-12 Japan Science & Technology Corp 脂溶性物質と生理活性高分子物質結合体および細胞核内への導入方法
HUE056941T2 (hu) * 2004-12-22 2022-04-28 Nitto Denko Corp Gyógyszerhordozó és gyógyszerhordozó kit fibrózis gátlására

Similar Documents

Publication Publication Date Title
JP2011201890A5 (https=)
JP2008050375A5 (https=)
JP2010138188A5 (https=)
Olejarz et al. Exosomes in angiogenesis and anti-angiogenic therapy in cancers
Sadakierska-Chudy MicroRNAs: diverse mechanisms of action and their potential applications as cancer epi-therapeutics
Rosińska et al. Tumor vessels fuel the fire in glioblastoma
Zhang et al. Mechanisms of angiogenesis in tumour
Kaur et al. Modified mRNA as a therapeutic tool for the heart
Liu et al. Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles
Kouri et al. miRNA-182 and the regulation of the glioblastoma phenotype-toward miRNA-based precision therapeutics
Hamada et al. Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer
Kheshtchin et al. Targeting hypoxia and hypoxia‐inducible factor‐1 in the tumor microenvironment for optimal cancer immunotherapy
Wu et al. Improving the intracellular drug concentration in lung cancer treatment through the codelivery of doxorubicin and miR-519c mediated by porous PLGA microparticle
Spugnini et al. Preclinical models in electrochemotherapy: the role of veterinary patients
RU2017136720A (ru) Средство для лечения фиброза почек
Song et al. Tetrahedral framework nucleic acid delivered RNA therapeutics significantly attenuate pancreatic cancer progression via inhibition of CTR1-dependent copper absorption
Beigi et al. Lipid-based nanocarriers for targeted gene delivery in lung cancer therapy: exploring a novel therapeutic paradigm
Obisi et al. Unveiling the future of cancer stem cell therapy: a narrative exploration of emerging innovations
Weintraub et al. Advances in intravesical therapy for the treatment of non‑muscle invasive bladder cancer
Sun et al. RNA binding proteins in extracellular vesicles and their potential value for cancer diagnosis and treatment
Gu et al. EGFR-targeted liposomes combined with ginsenoside Rh2 inhibit triple-negative breast cancer growth and metastasis
Gulati et al. Exosomes as theranostic targets: Implications for the clinical prognosis of aggressive cancers
Maphutha et al. The role of the PTEN tumor suppressor gene and its Anti-Angiogenic activity in melanoma and other cancers
Hanieh et al. Aryl hydrocarbon receptor as an anticancer target: an overview of ten years odyssey
Qi et al. Metabolic Reprogramming of Cancer‐Associated Fibroblasts: Transforming Tumor Accomplices into Immunotherapeutic Allies